In myeloid tumors, alterations in the TGF-β1 signaling pathway lead to upregulation of CTSB, and TGF-β1 stimulates the expression of CTSB mainly by inhibiting Smad1 132. This evidence concerns the gene CTSB and myeloid neoplasm.